You are here
Treatment of Agitation by drug Aerosol Inhalation
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43MH068926-01A1
Agency Tracking Number: MH068926
Amount:
$196,998.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
ALEXZA MOLECULAR DELIVERY CORPORATION
1001 E MEADOW CIR
PALO ALTO, CA
94303
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: PATRIK Munzar
Phone: (650) 687-3922
Email: PMUNZAR@ALEXZA.COM
Phone: (650) 687-3922
Email: PMUNZAR@ALEXZA.COM
Business Contact
Name: JOSHUA RABINOWITZ
Phone: (650) 687-3902
Email: JRABINOWITZ@ALEXZA.COM
Phone: (650) 687-3902
Email: JRABINOWITZ@ALEXZA.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Acute agitation is a serious and common complication of a variety of major psychiatric disorders, including dementia, schizophrenia and mania. In addition, it is one of the most detrimental factors in the continued
* Information listed above is at the time of submission. *